glp 1 nestle is looking to adapt its products to GLP-1 users https://www.abc27.com/national/nestle-tweaks-products-to-appeal-to-glp-1 -users/?utm_medium=social&utm_source=facebook_abc27_News Nestlé Health Science launches GLP-1

In a 68- and 72-week clinical trial studying Wegovy (2.4 mg) and Zepbound (15 mg) in patients without diabetes and with BMI 30, or BMI 27 with a weight-related condition, the average weight loss was 15% and 20%, when paired with diet and exercise changes (compared to 2.4% and 3.1%, respectively, with diet and exercise alone)

Effervescent Convenience: Effortlessly incorporate skin-enhancing nutrients into your daily routine with our easy-to-use effervescent tablets, ensuring optimal absorption and efficacy

Exp Ther Med (2016) 11:260915

J Atheroscler Thromb

The kinase LKB1 mediates glucose homeostasis in liver and therapeutic effects of metformin

The broader field has moved toward understanding the full pharmacology of the GHS-R1a receptor